[Assessment of therapeutic effect of losartan on diabetes mellitus with gas chromatography-based metabonomics].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 29(6): 719-24, 2007 Dec.
Article
em Zh
| MEDLINE
| ID: mdl-18595246
ABSTRACT
OBJECTIVE:
To assess the therapeutic effect of losartan on type 2 diabetes mellitus (DM2) with gas chromatography (GC)-based metabonomics.METHODS:
DM2 patients were dosed with losartan (100 mg/d) and urines were collected at week 8 and 12. The biochemical criteria (blood pressure, urinary albumen, urinary 8-hydroxy-2'-deoxyguanosine and blood creatinine) were analyzed. Urine samples were derivatived and analyzed by GC. Multivariate metabonomics analysis was performed after peak alignment.RESULTS:
After 8-12 weeks, losartan showed little curative effect and no remarked changes of biochemical criteria were observed. However, metabonomics analysis revealed that some biomarkers such as glucitol and inositol changed.CONCLUSION:
GC-based metabonomics analysis enables the rapid identification of metabolic differences and provides information concerning therapeutic effect of losartan.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Cromatografia Gasosa
/
Losartan
/
Diabetes Mellitus
/
Diabetes Mellitus Tipo 2
/
Hipoglicemiantes
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
Zh
Ano de publicação:
2007
Tipo de documento:
Article